Identification of exhausted CD8+ T-cell signatures for prognosis in multiple myeloma by integrated analysis of single-cell and bulk RNA-sequencing
Authors:
Open Access
- 1 June 2026
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (6) , 478
Abstract
Multiple myeloma (MM) exhibits an exhausted CD8+ T cell state. Therefore, this study aimed to investigate exhausted CD8+ T cell-related signatures and the underlying mechanisms in MM. Single-cell RNA sequencing (scRNA-seq) and RNA-seq data were downloaded, and the MM immune landscape was observed. Through differential expression analysis and weighted gene co-expression network analysis, differential exhausted CD8+ T cell-related genes (DETG) were selected. Univariate Cox, Kaplan-Meier analysis, machine learning algorithms, and receiver operator characteristic curves were used to select optimal prognostic DETGs and construct and evaluate a risk score model. Thirteen DETGs that were mainly involved in tumor-related pathways were selected. Among these DETGs, JunD proto-oncogene (JUND) and nuclear factor kappa B inhibitor alpha (NFKBIA) correlated strongly with MM survival and immune response. Hence, these genes were considered as effective prognostic genes in MM and used to construct a prognostic risk score model. The risk score model exhibited promising predictive ability on MM survival. JUND and NFKBIA expression levels in the cell communication pseudo-temporal analysis were synchronous with CD8+ T cell differentiation. A novel exhausted CD8+ T cell-related prognostic model was successfully established, which exhibited promising predictive ability for clinical prognosis and potential immunotherapeutic efficacy in patients with MM.Keywords
This publication has 52 references indexed in Scilit:
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasetsNucleic Acids Research, 2018
- Increased exhausted CD8+ T cells with programmed death‐1, T‐cell immunoglobulin and mucin‐domain‐containing‐3 phenotype in patients with multiple myelomaAsia-Pacific Journal of Clinical Oncology, 2018
- Single-cell mRNA quantification and differential analysis with CensusNature Methods, 2017
- Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patientsScientific Reports, 2016
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- NF‐κB and the link between inflammation and cancerImmunological Reviews, 2012
- Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic MalignanciesCurrent Molecular Pharmacology, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Haplotypic structure across the IκBα gene (NFKBIA) and association with multiple myelomaCancer Letters, 2007
- 1′-Acetoxychavicol Acetate Is a Novel Nuclear Factor κB Inhibitor with Significant Activity against Multiple Myeloma In vitro and In vivoCancer Research, 2005